4.81
4.18%
-0.21
Genenta Science Spa Adr stock is traded at $4.81, with a volume of 1,137.
It is down -4.18% in the last 24 hours and down -12.55% over the past month.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
See More
Previous Close:
$5.02
Open:
$5.05
24h Volume:
1,137
Relative Volume:
0.09
Market Cap:
$89.62M
Revenue:
-
Net Income/Loss:
$-12.63M
P/E Ratio:
-10.00
EPS:
-0.4808
Net Cash Flow:
$-12.18M
1W Performance:
-0.97%
1M Performance:
-12.55%
6M Performance:
+45.76%
1Y Performance:
-10.93%
Genenta Science Spa Adr Stock (GNTA) Company Profile
Name
Genenta Science Spa Adr
Sector
Industry
Phone
-
Address
-
Compare GNTA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
GNTA | 4.90 | 89.62M | 0 | -12.63M | -12.18M | -0.4808 |
VRTX | 467.19 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 760.91 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 566.22 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 230.54 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.55 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-29-23 | Resumed | ROTH MKM | Buy |
Jul-25-22 | Initiated | H.C. Wainwright | Buy |
Jan-13-22 | Initiated | Maxim Group | Buy |
Genenta Science Spa Adr Stock (GNTA) Latest News
Genenta Science CEO to present at U.S. Senate meeting - TipRanks
Genenta Science receives Buy rating amid trial approval - Investing.com
Company’s Banking Stock: Dissecting a 38.98% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Genenta Science Announces Shareholder MeetingTipRanks.com - TipRanks
DHR Stock Quote Price and Forecast - CNN
Danaher (DHR) Stock Price, News & Analysis - MarketBeat
Genenta Science Spa Adr Stock (GNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):